Peers EXCEL Trial to Improve Glycemic Control

University of Wisconsin, Madison14 enrolled

Overview

The purpose of the study is to gather input about the value of adding a newly developed diabetes self-management program to an existing diabetes self-management program. Participants will self-identify as African-American/Black with type 2 diabetes, and prescribed a diabetes medication. Participants can expect to be in the study for 6 months.

Both programs utilized in this study focus on topics such as diet, exercise, and stress. Both programs offer ideas to manage diabetes symptoms, discuss appropriate exercises, provide guidance on healthy eating, review the use of medicine, and offer tips on communicating with healthcare providers and voicing concerns to family members. The new program is culturally-tailored for African Americans and focuses on helping patients take their medicines as prescribed. The purpose of this research study is to evaluate this newly developed combined diabetes self-management program.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Type 2 Diabetes

Interventions

Peers LEADBEHAVIORAL

Two group session focusing on beliefs about medicines and diabetes, discrimination/mistrust, and communication with providers, and 2 peer-based phone calls from Ambassadors to occur weekly for weeks 3-8, then bi-weekly for weeks 9-12.

HLWDBEHAVIORAL

Weekly group sessions for two months. Sessions will last up to 2.5 hours and focus on a different diabetes self-management topic.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Between 18-90 years old * Self-identify as African-American * Diagnosis of Type 2 diabetes * Able to speak/read English * Self-report having a primary care provider who prescribes one diabetes medication * Diagnosed with diabetes for ≥1 year at point of care * Will reside in the geographical area throughout the study period * Self-reported nonadherence on the DOSE-nonadherence survey * ≥7.5% A1C Exclusion Criteria: * Self-reported bipolar or personality disorders, schizophrenia, Alcohol and Other Drug Abuse (AODA), dementia * Older adults who have a history of severe hypoglycemia requiring medical assistance or glucagon administration * Participating in another lifestyle or medication adherence program

Locations (1)

University of Wisconsin

Madison, Wisconsin, United States

Outcomes

Primary Outcomes

Change in blood glucose (hemoglobin A1C)

The hypothesis is that there will be a more significant change in mean A1C, which is clinically meaningful, for participants in Peers EXCEL as compared to those in HLWD.